v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Jun. 28, 2025
Jun. 29, 2024
Cash Flows from Operating Activities:    
Net income $ 34,031 $ 38,373
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 28,758 29,136
Amortization of fair value inventory step-up 2,436 5,239
Share-based compensation expense 9,312 7,628
Gain on repurchase of convertible senior notes, net 0 (12,600)
Gains on sales of property, plant and equipment (243) (14,291)
Deferred income taxes (3,231) (3,853)
Other non-cash operating activities 1,814 1,926
Change in operating assets and liabilities:    
Change in accounts receivable 3,557 7,970
Change in inventories 3,296 (36,228)
Change in prepaid income taxes 3,346 3,223
Change in other assets and other liabilities (17,785) (9,839)
Change in accounts payable and accrued expenses (47,896) (44,105)
Net cash provided by (used in) operating activities 17,395 (27,421)
Cash Flows from Investing Activities:    
Capital expenditures (3,754) (5,656)
Non-cash transfers from inventory to property, plant and equipment for Haemonetics equipment (11,460) (4,211)
Acquisitions 0 (149,151)
Proceeds from sale of property, plant and equipment 297 20,362
Other investments (18,083) (541)
Net cash used in investing activities (33,000) (139,197)
Cash Flows from Financing Activities:    
Proceeds from issuance of convertible notes 0 700,000
Repurchase of convertible senior notes 0 (185,500)
Purchase of capped call related to convertible notes 0 (88,200)
Term loan borrowings 0 250,000
Term loan redemption 0 (262,500)
Payments on revolving facility 0 50,000
Repayment of term loan borrowings (1,563) (1,563)
Debt issuance costs 0 (23,135)
Proceeds from employee stock purchase plan 3,476 3,441
Proceeds from exercise of stock options 462 961
Cash used to net share settle employee equity awards (4,781) (9,750)
Other financing activities (36) (62)
Net cash (used in) provided by financing activities (2,442) 333,692
Effect of exchange rates on cash and cash equivalents 4,182 (1,445)
Net Change in Cash and Cash Equivalents (13,865) 165,629
Cash and Cash Equivalents at Beginning of Period 306,763 178,800
Cash and Cash Equivalents at End of Period $ 292,898 $ 344,429